ACADIA PHARMACEUTICALS INC.: accumulated depreciation on property, plant and equipment

What this measure means

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Exact concept: us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• ACADIA PHARMACEUTICALS INC.: total assets
• ACADIA PHARMACEUTICALS INC.: total liabilities
• ACADIA PHARMACEUTICALS INC.: stockholders equity
• ACADIA PHARMACEUTICALS INC.: cash and cash equivalents
• ACADIA PHARMACEUTICALS INC.: net income or loss
• ACADIA PHARMACEUTICALS INC.: operating cash flow
• ACADIA PHARMACEUTICALS INC.: capital expenditure payments
• ACADIA PHARMACEUTICALS INC.: revenue
• ACADIA PHARMACEUTICALS INC.: contract revenue excluding tax
• ACADIA PHARMACEUTICALS INC.: financing cash flow
• ACADIA PHARMACEUTICALS INC.: investing cash flow
• ACADIA PHARMACEUTICALS INC.: retained earnings or deficit
• ACADIA PHARMACEUTICALS INC.: basic weighted-average shares
• ACADIA PHARMACEUTICALS INC.: diluted weighted-average shares
• ACADIA PHARMACEUTICALS INC.: basic earnings per share
• ACADIA PHARMACEUTICALS INC.: diluted earnings per share
• ACADIA PHARMACEUTICALS INC.: income tax expense or benefit
• ACADIA PHARMACEUTICALS INC.: net property, plant and equipment
• ACADIA PHARMACEUTICALS INC.: share-based compensation expense
• ACADIA PHARMACEUTICALS INC.: operating income or loss
• ACADIA PHARMACEUTICALS INC.: current assets
• ACADIA PHARMACEUTICALS INC.: current liabilities
• ACADIA PHARMACEUTICALS INC.: current accounts payable
• ACADIA PHARMACEUTICALS INC.: net finite-lived intangible assets
• ACADIA PHARMACEUTICALS INC.: net current accounts receivable
• ACADIA PHARMACEUTICALS INC.: operating expenses
• ACADIA PHARMACEUTICALS INC.: net inventory
• ACADIA PHARMACEUTICALS INC.: gross profit
• ACADIA PHARMACEUTICALS INC.: selling, general and administrative expense
• ACADIA PHARMACEUTICALS INC.: research and development expense
• ACADIA PHARMACEUTICALS INC.: common shares outstanding
• ACADIA PHARMACEUTICALS INC.: additional paid-in capital
• ACADIA PHARMACEUTICALS INC.: accumulated other comprehensive income or loss
• ACADIA PHARMACEUTICALS INC.: operating lease right-of-use asset
• ACADIA PHARMACEUTICALS INC.: operating lease liability
• ACADIA PHARMACEUTICALS INC.: gross property, plant and equipment
• ACADIA PHARMACEUTICALS INC.: net intangible assets excluding goodwill
• ACADIA PHARMACEUTICALS INC.: other noncurrent assets
• ACADIA PHARMACEUTICALS INC.: other noncurrent liabilities
• ACADIA PHARMACEUTICALS INC.: accrued current liabilities
• ACADIA PHARMACEUTICALS INC.: prepaid expenses and other current assets
• ACADIA PHARMACEUTICALS INC.: net deferred tax assets
• ACADIA PHARMACEUTICALS INC.: net deferred tax liabilities
• ACADIA PHARMACEUTICALS INC.: pre-tax income or loss from continuing operations
• ACADIA PHARMACEUTICALS INC.: profit or loss including noncontrolling interests
• ACADIA PHARMACEUTICALS INC.: comprehensive income or loss
• ACADIA PHARMACEUTICALS INC.: net income available to common stockholders
• ACADIA PHARMACEUTICALS INC.: general and administrative expense
• ACADIA PHARMACEUTICALS INC.: depreciation expense
• ACADIA PHARMACEUTICALS INC.: amortization of intangible assets
• ACADIA PHARMACEUTICALS INC.: other nonoperating income or expense
• ACADIA PHARMACEUTICALS INC.: current income tax expense or benefit
• ACADIA PHARMACEUTICALS INC.: deferred income tax expense or benefit
• ACADIA PHARMACEUTICALS INC.: income taxes paid, net
• ACADIA PHARMACEUTICALS INC.: proceeds from issuing common stock
• ACADIA PHARMACEUTICALS INC.: operating lease payments
• ACADIA PHARMACEUTICALS INC.: change in accounts receivable
• ACADIA PHARMACEUTICALS INC.: change in inventories
• ACADIA PHARMACEUTICALS INC.: change in accounts payable

Inspect the source

Entity

ACADIA PHARMACEUTICALS INC. / CIK 0001070494

Captured

2026-09-20T05:19:37.996Z

SEC response SHA-256

b715477790e2bc4da8926097c8339e6eadd0d719aa545289c22b84a7adf5e2d1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001070494.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))